Physician profile
John E Danneberger
NPI 1982608782
$1,552.79
in general payments reported to CMS, 2019-2025
20 companies · $56.73 in 2025
The $56.73 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $94.15 · 2021: $41.76 · 2022: $199 · 2023: $409 · 2024: $469 · 2025: $56.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $261.33 | 2019-2025 | Lupron Depot, Botox |
| Astellas Pharma US INC | $146.61 | 2021-2024 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $139.76 | 2024 | Provenge |
| Telix Pharmaceuticals | $117.45 | 2023 | Illuccix |
| Axonics, INC. | $97.34 | 2024 | Axonics |
| Urogen Pharma, INC. | $97.26 | 2023 | Jelmyto |
| Baxter Healthcare | $94.53 | 2024 | Tisseel |
| Neotract INC. | $94.15 | 2020 | |
| Pfizer INC. | $89.20 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.47 | 2019 | |
| Coloplast Corp | $67.65 | 2023 | Titan |
| Janssen Biotech, INC. | $53.73 | 2022-2024 | Erleada, Akeega |
| Innovation Technologies INC | $48.46 | 2022 | |
| Myovant Sciences INC. | $38.33 | 2022 | |
| Olympus America INC. | $36.67 | 2023-2025 | Tecoflex, Itind System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $26.29 | 2024 | |
| Boston Scientific Corporation | $20.72 | 2019 | |
| Endo Pharmaceuticals INC. | $15.80 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $15.77 | 2025 | |
| Laborie Medical Technologies Corp. | $13.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Danneberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.